Zydus Lifesciences appoints Nitin Parekh as President (Special Projects)
He has been associated with the Zydus Group since 2009
He has been associated with the Zydus Group since 2009
Zydus will work closely with the USFDA to address and resolve the observations in an expeditious manner
Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Marksans Pharma gets USFDA nod for acid reflux drug
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
Subscribe To Our Newsletter & Stay Updated